Mulder WJM - Search Results

1

Nanoimmunotherapy to treat ischaemic heart disease.

Duivenvoorden R, Senders ML, van Leent MMT, Pérez-Medina C, Nahrendorf M, Fayad ZA, Mulder WJM. Duivenvoorden R, et al. Among authors: mulder wjm. Nat Rev Cardiol. 2019 Jan;16(1):21-32. doi: 10.1038/s41569-018-0073-1. Nat Rev Cardiol. 2019. PMID: 30209355 Free PMC article. Review.

2

Magnetic and fluorescent nanoparticles for multimodality imaging.

Mulder WJ, Griffioen AW, Strijkers GJ, Cormode DP, Nicolay K, Fayad ZA. Mulder WJ, et al. Nanomedicine (Lond). 2007 Jun;2(3):307-24. doi: 10.2217/17435889.2.3.307. Nanomedicine (Lond). 2007. PMID: 17716176 Review.

3

Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.

Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, Fisher EA, Fayad ZA. Briley-Saebo KC, et al. J Magn Reson Imaging. 2007 Sep;26(3):460-79. doi: 10.1002/jmri.20989. J Magn Reson Imaging. 2007. PMID: 17729343 Review.

4

Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.

Mulder WJ, Strijkers GJ, Vucic E, Cormode DP, Nicolay K, Fayad ZA. Mulder WJ, et al. Top Magn Reson Imaging. 2007 Oct;18(5):409-17. doi: 10.1097/rmr.0b013e31815a0e7f. Top Magn Reson Imaging. 2007. PMID: 18025995 Review.

5

Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles.

Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA. Mulder WJ, et al. Magn Reson Med. 2007 Dec;58(6):1164-70. doi: 10.1002/mrm.21315. Magn Reson Med. 2007. PMID: 18046703 Free article.

6

Nanomedicine captures cardiovascular disease.

Mulder WJ, Fayad ZA. Mulder WJ, et al. Arterioscler Thromb Vasc Biol. 2008 May;28(5):801-2. doi: 10.1161/ATVBAHA.108.165332. Arterioscler Thromb Vasc Biol. 2008. PMID: 18421003 Free PMC article. No abstract available.

7

Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.

Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Briley-Saebo KC, et al. Circulation. 2008 Jun 24;117(25):3206-15. doi: 10.1161/CIRCULATIONAHA.107.757120. Epub 2008 Jun 9. Circulation. 2008. PMID: 18541740 Free PMC article.

8

Multimodality nanotracers for cardiovascular applications.

Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA. Mulder WJ, et al. Nat Clin Pract Cardiovasc Med. 2008 Aug;5 Suppl 2:S103-11. doi: 10.1038/ncpcardio1242. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18641599 Review.

9

An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.

Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. Cormode DP, et al. Small. 2008 Sep;4(9):1437-44. doi: 10.1002/smll.200701285. Small. 2008. PMID: 18712752

10

Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, Calcagno C, Barazza A, Gordon RE, Zanzonico P, Fisher EA, Fayad ZA, Mulder WJ. Cormode DP, et al. Nano Lett. 2008 Nov;8(11):3715-23. doi: 10.1021/nl801958b. Epub 2008 Oct 22. Nano Lett. 2008. PMID: 18939808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters